As the aforementioned polymorphisms are associated with the risk of melanoma, the objective of this study is to identify the association between CDKN2A variants and the susceptibility to melanoma development in the Colombian population, by means of case-control design. The gene discussed is CDKN2A; the disease is melanoma.